Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 C-reactive protein in rheumatology.

× No keyword cloud information.

34 in total

Review 1. Rheumatology: 2. What laboratory tests are needed?

Authors: K Shojania
Journal: CMAJ Date: 2000-04-18 Impact factor: 8.262

2. The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms.

Authors: Victoria K Shanmugam; James McCloskey; Beth Elston; Sandra J Allison; Jennifer Eng-Wong
Journal: Breast Cancer Res Treat Date: 2011-11-11 Impact factor: 4.872

3. Is DAS28-CRP with three and four variables interchangeable in individual patients selected for biological treatment in daily clinical practice?

Authors: Ole Rintek Madsen
Journal: Clin Rheumatol Date: 2011-09-29 Impact factor: 2.980

4. Interchangeability of 28-joint disease activity scores using the erythrocyte sedimentation rate or the C-reactive protein as inflammatory marker.

Authors: Liseth Siemons; Harald E Vonkeman; Peter M ten Klooster; Piet L C M van Riel; Mart A F J van de Laar
Journal: Clin Rheumatol Date: 2014-02-23 Impact factor: 2.980

5. Anti-inflammatory and antioxidant effect of Kerabala: a value-added ayurvedic formulation from virgin coconut oil inhibits pathogenesis in adjuvant-induced arthritis.

Authors: M Ratheesh; S Sandya; C Pramod; S Asha; Jose P Svenia; S Premlal; B GrishKumar
Journal: Inflammopharmacology Date: 2016-11-22 Impact factor: 4.473

6. Protective effects of isolated polyphenolic and alkaloid fractions of Ruta graveolens L. on acute and chronic models of inflammation.

Authors: M Ratheesh; G L Shyni; G Sindhu; A Helen
Journal: Inflammation Date: 2010-02 Impact factor: 4.092

C-reactive protein in rheumatology.

Review 1. Rheumatology: 2. What laboratory tests are needed?

2. The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms.

3. Is DAS28-CRP with three and four variables interchangeable in individual patients selected for biological treatment in daily clinical practice?

4. Interchangeability of 28-joint disease activity scores using the erythrocyte sedimentation rate or the C-reactive protein as inflammatory marker.

5. Anti-inflammatory and antioxidant effect of Kerabala: a value-added ayurvedic formulation from virgin coconut oil inhibits pathogenesis in adjuvant-induced arthritis.

6. Protective effects of isolated polyphenolic and alkaloid fractions of Ruta graveolens L. on acute and chronic models of inflammation.

7. Degradation of rat C-reactive protein by macrophages.

8. The biological tests used in acute-phase of inflammation in bone infection : Clinical study.

9. Calprotectin levels in patients with rheumatoid arthritis to assess and association with exercise treatment.

10. Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis.